Tag: insulin delivery devices industry analysis

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Insulin Delivery Devices Market Value Growth And Long-Term Outlook#_x000D_

The market size for insulin delivery devices has demonstrated substantial growth over recent years. It is forecast to grow from $19.07 billion in 2025 to $20.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. Historically, this expansion has been driven by the rising prevalence of diabetes, growing awareness of diabetes management, increased availability of insulin therapies, expansion of healthcare access, and a rising adoption of self-injection practices._x000D_

_x000D_

The insulin delivery devices market is anticipated to experience robust expansion over the coming years. This sector is projected to reach a valuation of $28.03 billion by 2030, demonstrating an 8.0% compound annual growth rate (CAGR). The primary drivers for this growth during the forecast period include the expanding global diabetic population, a heightened need for convenient methods of insulin delivery, increased emphasis on long-term diabetes management, broader access to diabetes care in developing regions, and the growing integration of home healthcare solutions. Key developments expected during this period involve a greater shift towards insulin pens compared to conventional syringes, a surge in demand for insulin pumps offering continuous delivery, an increasing preference for intuitive and portable insulin devices, the broadening of home-based diabetes management options, and an escalated use of disposable and pre-filled insulin delivery solutions._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=74999484&type=smp&name=Insulin%20Delivery%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Insulin Delivery Devices Market Expansion Drivers: What’s Shaping Future Growth?#_x000D_

The increasing incidence of diabetes is projected to drive the expansion of the insulin delivery devices market in the future. Diabetes is defined as a chronic condition characterized by elevated blood sugar levels, stemming from either inadequate insulin production by the pancreas or the body’s inability to effectively use insulin. The rise in diabetes rates globally is primarily due to factors such as sedentary lifestyles, unhealthy diets, and escalating obesity rates. Insulin delivery devices are essential for individuals with diabetes to efficiently manage their blood sugar levels by administering insulin in a controlled and convenient manner, thus preventing complications and promoting health. For instance, according to the International Diabetes Federation, a Belgium-based non-governmental organization, in 2024, approximately 589 million adults aged 20–79 are living with diabetes worldwide. This figure is projected to increase to 853 million by 2050. Consequently, the expanding prevalence of diabetes is a significant driver for the growth of the insulin delivery devices market._x000D_

_x000D_

#Insulin Delivery Devices Market Segment Analysis And Revenue Potential#_x000D_

The insulin delivery devices market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens_x000D_

2) By Disease Indication: Type 1, Type 2_x000D_

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers_x000D_

_x000D_

Subsegments:_x000D_

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length _x000D_

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors _x000D_

3) By Pen Needles: Short Pen Needles, Long Pen Needles _x000D_

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens _x000D_

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens_x000D_

_x000D_

#Insulin Delivery Devices Market Strategic Trends: What Defines The Next Growth Phase?#_x000D_

Leading companies in the insulin delivery devices sector are actively developing innovative products, such as insulin pumps, designed to offer continuous or customizable insulin administration. Insulin pumps are programmable medical devices that deliver insulin either continuously or as required through a catheter placed beneath the skin. For instance, in May 2023, Beta Bionics, a US-based medical technology firm, announced that its iLet ACE Pump and iLet Dosing Decision Software received U.S. Food and Drug Administration approval. The iLet Bionic Pancreas system is engineered for individuals aged six and older diagnosed with type 1 diabetes, merging two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). It operates using an automated insulin dosing (AID) system, driven by an adaptive closed-loop algorithm, which initially only requires the user’s body weight for setup, thereby eliminating the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system necessitates no manual adjustment of settings, which simplifies its initiation and management. The iLet device also features a meal announcement capability that streamlines mealtime insulin dosing by classifying meals as small, medium, or large, with the underlying algorithm learning and adapting to individual insulin requirements over time._x000D_

_x000D_

#Insulin Delivery Devices Market Company Landscape And Competitive Strategy#_x000D_

Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation _x000D_

_x000D_

#View The Full Insulin Delivery Devices Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Insulin Delivery Devices Market Largest Region: Which Geography Holds The Biggest Share?#_x000D_

North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Insulin Delivery Devices Market Projected To Expand During 2026–2030?

The insulin delivery devices market has seen significant expansion in recent years. It is forecast to grow from $19.07 billion in 2025 to $20.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.1%. The market’s historical growth can be attributed to factors such as the increasing incidence of diabetes, heightened understanding of diabetes management, the broader availability of insulin treatments, expanded access to healthcare, and a surge in the practice of self-injection.

The insulin delivery devices market size is projected for substantial expansion over the upcoming years. This market is anticipated to reach $28.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. The expansion during the forecast period can be linked to an escalating global diabetic population, a heightened need for convenient insulin delivery methods, a strengthening focus on long-term diabetes management, broader access to diabetes care in emerging markets, and the increasing adoption of home healthcare solutions. Prominent trends expected in this period include a rising preference for insulin pens over traditional syringes, an increasing demand for insulin pumps for continuous insulin delivery, a growing inclination towards user-friendly and portable insulin devices, the spread of home-based diabetes management solutions, and an expanding use of disposable and pre-filled insulin delivery devices.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Core Drivers Are Transforming The Insulin Delivery Devices Market?

The increasing occurrence of diabetes is anticipated to fuel the expansion of the insulin delivery devices market in the future. This chronic illness is characterized by elevated blood sugar levels, resulting from either insufficient insulin production by the pancreas or the body’s impaired ability to utilize insulin effectively. Globally, the rise in diabetes rates is largely attributed to sedentary lifestyles, unhealthy dietary habits, and escalating obesity. Insulin delivery devices are vital for managing diabetes, enabling individuals to control their blood sugar levels efficiently through convenient and controlled insulin administration, thereby preventing adverse health outcomes and promoting better health. For example, the International Diabetes Federation, a Belgium-based non-governmental organization, reported that in 2024, approximately 589 million adults aged 20–79 worldwide are living with diabetes. This figure is projected to reach 853 million by 2050. Hence, the increasing prevalence of diabetes is a significant impetus for the growth of the insulin delivery devices market.

How Is Segment Classification Applied In The Insulin Delivery Devices Market?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

What Trends Are Affecting The Insulin Delivery Devices Market Dynamics?

Leading firms in the insulin delivery devices market are creating novel products, like insulin pumps, to facilitate either continuous or personalized insulin administration. These programmable medical devices administer insulin constantly or on demand through a catheter inserted beneath the skin. As an illustration, in May 2023, Beta Bionics, a US-based medical technology company, received U.S. Food and Drug Administration approval for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system is intended for individuals aged six and older with type 1 diabetes, integrating two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). This system functions via an automated insulin dosing (AID) mechanism powered by an adaptive closed-loop algorithm, which initially requires only the user’s body weight for setup and removes the necessity for additional insulin dosing parameters. In contrast to traditional pump therapy, this system does not demand manual adjustment of settings, thus simplifying its initiation and management. Furthermore, the iLet device incorporates a meal announcement feature that streamlines mealtime insulin dosing by classifying meals as small, medium, or large, with the algorithm continuously learning and adapting to individual insulin requirements.

Which Organizations Are Operating Within The Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

Access The Complete Insulin Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Region Has The Strongest Presence In The Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Insulin Delivery Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2026, By The Business Research Company

Wearable Ai Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-ai-global-market-report

Smart Wearables Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-wearables-global-market-report

Wearable Computing Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-computing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Insulin Delivery Devices Market Projected To Reach By 2030?

The insulin delivery devices market size has experienced robust growth in recent years. It is forecast to increase from $19.07 billion in 2025 to $20.61 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.1%. This historical expansion can be attributed to the rising prevalence of diabetes, growing awareness of diabetes management, increased availability of insulin therapies, expansion of healthcare access, and rising adoption of self-injection practices.

The insulin delivery devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $28.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period stems from factors such as a rising worldwide diabetic population, an escalating need for user-friendly insulin administration techniques, a heightened emphasis on managing diabetes over the long term, broader availability of diabetes treatment in developing economies, and increased uptake of home-based healthcare options. Key trends projected for this period involve a greater shift towards insulin pens instead of conventional syringes, an increasing requirement for insulin pumps for uninterrupted insulin supply, a growing preference for easy-to-use and portable insulin equipment, the expansion of diabetes management solutions within the home environment, and a wider deployment of disposable and pre-filled insulin delivery units.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

Which Major Drivers Are Influencing The Expansion Of The Insulin Delivery Devices Market?

The increasing occurrence of diabetes is anticipated to drive the expansion of the insulin delivery devices market in the future. This chronic ailment is characterized by elevated blood sugar levels, stemming from either insufficient insulin generation by the pancreas or the body’s impaired capacity to use insulin properly. The escalation in diabetes cases is predominantly attributed to factors like inactive lifestyles, poor dietary habits, and a global surge in obesity. Insulin delivery devices are essential for individuals with diabetes to efficiently regulate their blood sugar levels through precise and user-friendly insulin administration, thus averting health complications and fostering well-being. As an illustration, the International Diabetes Federation, a Belgium-based non-governmental organization, reported that in 2024, approximately 589 million adults aged 20–79 globally are afflicted with diabetes. This figure is forecasted to climb to 853 million by 2050. Consequently, the expanding incidence of diabetes is fueling the development of the insulin delivery devices market.

How Is The Insulin Delivery Devices Market Broken Down By Segment Categories?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

Which Trends Are Shaping The Insulin Delivery Devices Market?

Leading companies within the insulin delivery devices market are developing innovative products, including insulin pumps, to provide continuous or customizable insulin delivery. These programmable medical devices deliver insulin continuously or on demand via a catheter placed subcutaneously. For instance, in May 2023, US-based medical technology company Beta Bionics announced U.S. Food and Drug Administration approval for its iLet ACE Pump and the iLet Dosing Decision Software. Aimed at individuals aged six and older with type 1 diabetes, the iLet Bionic Pancreas system integrates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). Operating through an automated insulin dosing (AID) system powered by an adaptive closed-loop algorithm, it initially uses only the user’s body weight for setup, thereby eliminating the need for additional insulin dosing parameters. Distinguishing itself from traditional pump therapy, this system requires no manual adjustment of settings, which simplifies its initiation and management. Additionally, the iLet device incorporates a meal announcement feature, streamlining mealtime insulin dosing by categorizing meals as small, medium, or large, as the algorithm learns and adapts to individual insulin requirements over time.

Which Players Are Present In The Insulin Delivery Devices Market Space?

Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

Get The Full Insulin Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Region Is The Leading Market For The Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Insulin Delivery Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2026, By The Business Research Company

Wearable Ai Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-ai-global-market-report

Smart Wearables Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-wearables-global-market-report

Wearable Computing Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-computing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Insulin Delivery Devices Market Between 2026 And 2030?

The insulin delivery devices market has demonstrated significant expansion in recent years. Its value is expected to rise from $19.07 billion in 2025 to $20.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. Over the past period, this growth has been fueled by the increasing prevalence of diabetes, enhanced awareness concerning diabetes management, improved access to insulin therapies, the broadening of healthcare services, and the growing adoption of self-injection techniques.

The insulin delivery devices market is poised for significant expansion over the upcoming years. Its valuation is projected to reach $28.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period stems from factors such as an expanding global diabetic population, a heightened need for user-friendly insulin delivery approaches, an increased emphasis on managing diabetes over the long term, broader availability of diabetes care in developing economies, and the greater uptake of home healthcare solutions. Key trends identified for the forecast timeframe involve a surge in the use of insulin pens compared to conventional syringes, an escalating requirement for insulin pumps to facilitate continuous insulin administration, a stronger inclination towards insulin devices that are easy to use and portable, an increase in home-centered diabetes management options, and an expanding utilization of disposable and pre-filled insulin delivery systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Drivers Are Influencing The Insulin Delivery Devices Market?

The rising occurrence of diabetes is anticipated to drive the expansion of the insulin delivery devices market in the future. This chronic ailment, diabetes, is characterized by elevated blood sugar concentrations, stemming from either insufficient insulin synthesis by the pancreas or the body’s incapacity to properly use insulin. The incidence of diabetes is escalating mainly as a result of elements like inactive lifestyles, poor dietary habits, and an uptick in global obesity levels. For individuals with diabetes, insulin delivery devices are essential tools that facilitate the effective regulation of blood sugar levels through controlled and convenient insulin administration, thus averting complications and fostering well-being. As an illustration, data from the International Diabetes Federation, a Belgium-based non-governmental organization, indicates that in 2024, roughly 589 million adults aged 20–79 globally are afflicted with diabetes. This figure is predicted to climb to 853 million by 2050. Consequently, the increasing spread of diabetes is fueling the expansion of the insulin delivery devices market.

Which Market Segments Are Examined In The Insulin Delivery Devices Market Study?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

Which Trends Are Influencing The Insulin Delivery Devices Market?

Leading companies within the insulin delivery devices market are developing innovative products, such as insulin pumps, to offer continuous or customizable insulin administration. Insulin pumps are programmable medical instruments that deliver insulin consistently or on demand through a catheter inserted beneath the skin. For example, in May 2023, Beta Bionics, a US-based medical technology firm, announced U.S. Food and Drug Administration approval for both the iLet ACE Pump and the iLet Dosing Decision Software. The iLet Bionic Pancreas system is engineered for individuals aged six and older with type 1 diabetes, integrating two components with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). It operates via an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which initially only uses the user’s body weight for setup and removes the requirement for additional insulin dosing parameters. Unlike traditional pump therapy, this system necessitates no manual adjustment of settings, thereby simplifying its initiation and management. The iLet device also includes a meal announcement feature that streamlines mealtime insulin dosing by classifying meals as small, medium, or large, with the algorithm learning and adapting to individual insulin needs over time.

Who Are The Primary Competitors In The Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

Read the full insulin delivery devices market report here:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Insulin Delivery Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2026, By The Business Research Company

Wearable Ai Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-ai-global-market-report

Smart Wearables Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-wearables-global-market-report

Wearable Computing Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-computing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Insulin Delivery Devices Market be in 2030 compared with 2026?

The insulin delivery devices market has experienced significant expansion in recent years. This market is projected to grow from $19.07 billion in 2025 to $20.61 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.1%. The growth observed in previous periods can be attributed to factors such as the increasing prevalence of diabetes, heightened awareness surrounding diabetes management, improved availability of insulin therapies, wider access to healthcare, and the increasing adoption of self-injection methods.

The insulin delivery devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $28.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This projected increase can be ascribed to several factors, such as an expanding global diabetic population, a heightened need for user-friendly insulin administration techniques, a greater emphasis on sustained diabetes care, improved availability of diabetes treatment in developing economies, and the broader embrace of at-home medical care options. Key developments expected during this timeframe encompass a shift towards insulin pens instead of conventional syringes, an increasing requirement for insulin pumps for ongoing insulin administration, a stronger inclination towards easy-to-use and portable insulin apparatus, the expansion of diabetes management strategies tailored for home environments, and an uptick in the utilization of single-use and pre-filled insulin delivery devices.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Drivers Are Guiding Growth Patterns In The Insulin Delivery Devices Market?

The increasing incidence of diabetes is anticipated to drive expansion within the insulin delivery devices market in the future. Diabetes is a chronic ailment characterized by elevated blood sugar levels, resulting from insufficient insulin secretion by the pancreas or the body’s incapacity to properly use insulin. The rise in diabetes cases is predominantly linked to factors like inactive lifestyles, poor dietary habits, and a global increase in obesity. For individuals with diabetes, insulin delivery devices are essential tools that enable effective management of blood sugar by providing insulin in a controlled and convenient way, thus averting complications and fostering overall well-being. As an illustration, the International Diabetes Federation, a Belgium-based non-governmental organization, reported that in 2024, approximately 589 million adults aged 20–79 globally are afflicted with diabetes. This figure is forecast to escalate to 853 million by 2050. Consequently, the expanding prevalence of diabetes is fueling the growth of the insulin delivery devices market.

Which Segments Are Driving Activity In The Insulin Delivery Devices Market?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

What Trends Are Reshaping The Dynamics Of The Insulin Delivery Devices Market?

Leading firms within the insulin delivery devices sector are creating advanced products, such as insulin pumps, to offer uninterrupted or tailored insulin administration. Insulin pumps are programmable medical instruments designed to deliver insulin continuously or on demand through a subcutaneous catheter. As an illustration, in May 2023, Beta Bionics, a US-based medical technology company, declared the U.S. Food and Drug Administration’s endorsement for its iLet ACE Pump and the iLet Dosing Decision Software. The iLet Bionic Pancreas system is engineered for individuals aged six and above who have type 1 diabetes, integrating two devices with a compatible FDA-approved integrated continuous glucose monitor (iCGM). It functions through an automated insulin dosing (AID) system powered by an adaptive closed-loop algorithm, which initially requires only the user’s body weight for configuration, removing the necessity for extra insulin dosing parameters. In contrast to conventional pump therapy, this particular system eliminates the need for manual setting adjustments, thereby easing its setup and ongoing management. Furthermore, the iLet device incorporates a meal announcement capability that streamlines mealtime insulin delivery by classifying meals into small, medium, or large categories, with the underlying algorithm progressively learning and adapting to individual insulin demands.

Which Key Players Are Driving Competition In The Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

How Does The Insulin Delivery Devices Market Perform Across Major Global Regions?

North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Insulin Delivery Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2026, By The Business Research Company

Wearable Ai Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-ai-global-market-report

Smart Wearables Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-wearables-global-market-report

Wearable Computing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-computing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the insulin delivery devices market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Insulin Delivery Devices Market Now And By 2029?

The insulin delivery devices market size has seen strong expansion over recent years. This market is expected to increase from $17.71 billion in 2024 to $19.07 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.7%. The growth observed in the past can be attributed to the convenience and ease of use provided by insulin delivery devices, beneficial reimbursement policies, the rising prevalence of obesity, an expanding aging population, and the increasing embrace of insulin pumps.

The insulin delivery devices market is anticipated to show significant expansion over the next few years. It is projected to reach $25.98 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.0%. This observed growth within the forecast period can be attributed to the rising prevalence of the diabetic population, increasing healthcare expenditure on diabetes care, the emergence of continuous glucose monitoring systems, a growing awareness among patients regarding the benefits of automated insulin delivery devices, and an enhanced focus on healthcare. Key trends during this period are expected to include technological advancements in insulin delivery devices, the integration of digital technology with these devices, the development of artificial pancreas systems, innovations in insulin administration technology, and advancements in bionic technology.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

Which Long-Term Drivers Are Expected To Sustain The Insulin Delivery Devices Market?

The increasing incidence of diabetes is projected to drive expansion within the insulin delivery devices market in the future. This chronic ailment is characterized by elevated blood sugar, resulting from either insufficient insulin creation by the pancreas or the body’s impaired capacity to use insulin properly. The rise in diabetes diagnoses is largely attributed to factors like inactive lifestyles, poor dietary habits, and a global surge in obesity. These devices are essential for individuals with diabetes, facilitating the effective management of blood sugar through controlled and convenient insulin administration, which helps prevent complications and supports overall well-being. For example, data from December 2022, provided by the US government agency, the Centers for Disease Control and Prevention, suggests that the population of young individuals under 20 diagnosed with type 2 diabetes in the United States could see an almost 700% increase by 2060, potentially reaching 220,000 people. During this identical timeframe, new diagnoses of type 1 diabetes among this young demographic might increase by up to 65%. Consequently, the expanding occurrence of diabetes is fueling the growth of the insulin delivery devices market.

How Is The Insulin Delivery Devices Market Classified By Different Segments?

The insulin delivery devicesmarket covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

What Current And Upcoming Trends Are Shaping The Insulin Delivery Devices Market?

Leading companies within the insulin delivery devices market are developing innovative solutions, such as insulin pumps, to ensure continuous or personalized insulin provision. These insulin pumps are programmable medical devices designed to deliver insulin without interruption or on an as-needed basis via a catheter placed under the skin. For example, in May 2023, Beta Bionics, a US-based medical technology company, announced that the U.S. Food and Drug Administration had approved its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system is intended for individuals aged six and older living with type 1 diabetes, combining two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). It operates through an automated insulin dosing (AID) system, driven by an adaptive closed-loop algorithm that initially only requires the user’s body weight for setup, thereby eliminating the need for additional insulin dosing parameters. Distinct from traditional pump therapy, this system requires no manual adjustment of settings, which simplifies both its initiation and ongoing management. The iLet device also features a meal announcement capability that streamlines mealtime insulin dosing by allowing users to categorize meals as small, medium, or large, with the algorithm learning and adapting to individual insulin requirements over time.

Who Are The Primary Market Leaders In The Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2025, By The Business Research Company

Insulin Pens Syringes Pumps And Injectors Market 2025

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Insulin Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Smart Insulin Pens Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Insulin Delivery Devices Market Between 2025 And 2029?

The realm of insulin delivery apparatuses has experienced substantial expansion lately; its market valuation is projected to ascend from $17.71 billion in the year 2024 to reach $19.07 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 7.7%. This past period’s upward trajectory is largely explained by the convenience and user-friendliness inherent in these devices, alongside supportive reimbursement frameworks, the rising incidence of obesity, an expanding demographic of older individuals, and greater acceptance of insulin pump technology.

Anticipating considerable expansion over the coming years, the arena for insulin delivery mechanisms is projected to reach a substantial valuation of $25.98 billion by the year 2029, reflecting a consistent compound annual growth rate of 8.0%; this upward trajectory is fundamentally driven by the escalating incidence of diabetes globally, augmented spending within healthcare sectors dedicated to diabetes management, the wider adoption of continuous glucose monitoring apparatus, heightened patient understanding regarding the advantages offered by automated insulin delivery tools, and a general intensification of healthcare priorities. Key shifts shaping this market throughout the projection timeframe encompass innovations in the design of insulin delivery gadgets, the incorporation of digital functionalities into these systems, progress in creating fully artificial pancreas solutions, enhancements in the methods used for administering insulin, and breakthroughs in bionic technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

Which Drivers Are Supporting Growth Of The Insulin Delivery Devices Market?

The escalating incidence of diabetes is anticipated to serve as a significant catalyst for the expansion of the market for insulin administration apparatuses in the near future. Diabetes, characterized by persistently elevated blood glucose levels stemming from insufficient insulin generation by the pancreas or the body’s failure to use insulin efficiently, represents a long-term health challenge. This upward trend in diabetes cases is largely attributable to global shifts toward more inactive ways of living, less nutritious eating patterns, and increasing levels of corpulence. To maintain optimal health and avert complications, individuals with diabetes rely upon insulin delivery instruments to achieve regulated and user-friendly insulin administration for blood sugar control. Illustratively, data released in December 2022 by the Centers for Disease Control and Prevention, a US governmental authority, projected that the count of adolescents under twenty years old diagnosed with type 2 diabetes within the United States might surge by approximately 700 percent by the year 2060, possibly affecting as many as 220,000 youths; concurrently, projected increases for new type 1 diabetes identifications in this same age group could reach a substantial 65 percent, underscoring that expanding diabetes figures are directly fueling the progression of the insulin delivery device sector.

What Are The Different Segment Classifications Within The Insulin Delivery Devices Market?

The insulin delivery devicesmarket covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

What Key Innovation Trends Are Fueling Advancements In The Insulin Delivery Devices Market?

Leading enterprises within the insulin delivery apparatus sector are actively crafting novel solutions, including insulin pumps, designed to facilitate either uninterrupted or user-tailored insulin administration. These sophisticated, programmable medical instruments dispense insulin either constantly or on demand via a tube inserted subcutaneously. To illustrate, in May of 2023, Beta Bionics, an American med-tech firm, confirmed receiving clearance from the U.S. Food and Drug Administration for both its iLet ACE Pump and the accompanying iLet Dosing Decision Software. This iLet Bionic Pancreas apparatus targets people aged six and above diagnosed with type 1 diabetes, integrating two components alongside an already authorized continuous glucose monitoring system (iCGM). Functioning via an automated insulin delivery (AID) mechanism powered by a sophisticated, adaptive closed-loop algorithm, the initial setup relies solely on the patient’s body mass, thereby removing the necessity of inputting various supplemental insulin dosage specifications. A significant departure from conventional pump treatments, this technology negates the requirement for manual modification of operational parameters, thus streamlining both the commencement and ongoing maintenance processes. Furthermore, the iLet hardware incorporates a system for announcing meals, which streamlines the calculation of insulin doses required for eating by classifying meals into simple categories such as small, medium, or large, with the inherent algorithm progressively refining its understanding of the patient’s unique insulin needs over time.

Which Key Market Players Are Investing In Expansion And Innovation Of Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Geographies Are Emerging As Strong Markets For The Insulin Delivery Devices Industry?

North America was the largest region in the insulin delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Insulin Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2025, By The Business Research Company

Insulin Pens Syringes Pumps And Injectors Market 2025

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Insulin Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Smart Insulin Pens Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Insulin Delivery Devices Market Expected to Grow Between 2025 And 2029?

The market for insulin delivery devices has seen a robust growth in recent years. It is projected to rise from $17.71 billion in 2024 to $19.07 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be credited to the convenience and user-friendliness of these insulin delivery devices, positive reimbursement policies, a rise in obesity rates, a growing elderly population, and an increased uptake of insulin pumps.

The market for insulin delivery devices is projected to experience robust growth in the coming years, expanding to a value of $25.98 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. This increase in the forecast period is credited to the escalating prevalence of diabetes, higher diabetes care spending, the emergence of continuous glucose monitoring systems, heightened patient awareness of the advantages of automated insulin delivery devices, and a growing emphasis on healthcare. Notable trends over the forecast period encompass advancements in the technology of insulin delivery devices, assimilation of digital technology into these devices, progress in the production of artificial pancreas systems and advancements in insulin administration technology, along with bionic technology developments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Are the Core Market Drivers Propelling Growth in the Insulin Delivery Devices Industry?

The surge in diabetes incidents is predicted to propel insulin delivery devices’ market expansion in the future. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or the body’s inefficient use of insulin, is a long-term health concern. It has been observed that the rate of diabetes is escalating due to inactive lifestyles, unhealthy eating habits, and increasing global obesity rates. Insulin delivery devices are necessary for managing diabetes as these devices enable one to regulate blood sugar levels methodically and conveniently by delivering insulin, thus averting complications and promoting wellbeing. For instance, according to a forecast from the Centers for Disease Control and Prevention in December 2022, the number of children and young adults in the US with type 2 diabetes could see about a 700% increase by 2060, affecting around 220,000 individuals. Simultaneously, there could be an increase in type 1 diabetes diagnoses by nearly 65% among the same group. Consequently, the escalating incidents of diabetes are fueling the growth of the insulin delivery devices market.

How Is the Insulin Delivery Devices Market Segmented?

The insulin delivery devicesmarket covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Which Regions Are Driving the Next Phase of the Insulin Delivery Devices Market Growth?

North America was the largest region in the insulin delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Insulin Delivery Devices Industry?

Leading companies in the insulin delivery devices market are creating advanced products like insulin pumps which facilitate continuous and customizable delivery of insulin. Insulin pumps are programmable health devices that administer insulin either continuously or when necessary through a catheter installed under the skin. For example, Beta Bionics, a medical tech company based in the US, announced in May 2023 that the iLet ACE Pump and the iLet Dosing Decision Software had been approved by the U.S. Food and Drug Administration. The iLet Bionic Pancreas system is formulated for people aged six and older with type 1 diabetes. It merges two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM) and uses an automated insulin dosing (AID) system powered by an adaptive closed-loop algorithm. This system does not require any manual adjustment of settings and it’s easier to start and manage. It also has a meal announcement feature that simplifies mealtime insulin dosing by classifying meals into small, medium, or large, and the algorithm adapts to individual insulin needs over time.

View the full report here:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

How Is the Insulin Delivery Devices Market Defined and What Are Its Core Parameters?

Insulin delivery devices refer to medical tools designed to administer insulin into the body of a person with diabetes. These devices are crucial for managing blood glucose levels in individuals who cannot produce sufficient insulin naturally. These devices are used to manage blood sugar levels effectively, providing flexibility and convenience in insulin administration.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Insulin Delivery Devices Market From 2025 To 2029?

The market for insulin delivery devices has experienced significant growth in recent times. It is projected to expand from a size of $17.71 billion in 2024 to $19.22 billion in 2025, experiencing a compound annual growth rate (CAGR) of 8.5%. Contributing factors to the growth seen during the historical period include the convenience and user-friendliness of insulin delivery devices, advantageous reimbursement policies, a rising prevalence of obesity, a growing elderly population, and an increased uptake of insulin pumps.

What Is the Projected Market Size of the Insulin Delivery Devices Market?

The market for insulin delivery devices is anticipated to experience significant growth in the coming years, predicting a rise to $26.3 billion by 2029 with a compound annual growth rate (CAGR) of 8.2%. This expected growth during the forecasted period can be credited to an increasing number of diabetic patients, higher healthcare spending on treating diabetes, the emergence of continuous glucose monitoring systems, increased patient awareness about the advantages of using automated insulin delivery systems, and a growing emphasis on healthcare. Key forecast period trends encompass advancements in insulin delivery device technology, the combination of digital technology with insulin delivery devices, the creation of artificial pancreas systems, progress in insulin administration technology, and bionic technology’s advancements.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

Who are the Major Competitors in the Insulin Delivery Devices Market Outlook?

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

What Is Fueling Growth in the Insulin Delivery Devices Market?

The insulin delivery devices market is predicted to expand due to the increasing incidence of diabetes. Diabetes, a chronic illness characterized by elevated blood sugar levels, can result from either insufficient production of insulin from the pancreas or the body’s failure to use insulin efficiently. The rise in diabetes is primarily attributed to factors like inactive lifestyles, unhealthy eating habits, and growing obesity rates worldwide. Insulin delivery devices are vital for managing diabetes as they allow the controlled and convenient administration of insulin, thereby averting complications and supporting health. For example, the Centers for Disease Control and Prevention, a US government agency, stated in December 2022 that the count of youngsters under 20 years with type 2 diabetes in the United States could surge by an estimated 700% by 2060, potentially affecting around 220,000 individuals. Simultaneously, diagnoses of type 1 diabetes among young people could increase by up to 65%. Hence, the rising prevalence of diabetes is fueling the insulin delivery devices market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Which Insulin Delivery Devices Market Segments Are Growing the Fastest?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

Which Industry Trends Are Shaping the Future of the Insulin Delivery Devices Market?

Leading corporations in the insulin delivery devices sector are prioritizing the invention of cutting-edge products, including insulin pumps, to offer either constant or customizable insulin delivery. Insulin pumps are medical devices that can be programmed to administer insulin either continuously or on an as-needed basis through a catheter inserted beneath the skin. For example, in May 2023, Beta Bionics, a medical technology company from the U.S., received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and the iLet Dosing Decision Software. Tailored for individuals who are six years of age or older and have type 1 diabetes, the iLet Bionic Pancreas system amalgamates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). Its functionality is reliant on an automated insulin dosing (AID) system propelled by an adaptive closed-loop algorithm, initially predicated solely on the user’s weight, thus eliminating the need for extra insulin dosing criteria. This system doesn’t require any manual setting adjustments in contrast with the conventional pump treatment, making it more user-friendly. Additionally, the iLet device unveils a feature that simplifies mealtime insulin dosing by dividing meals into small, medium, or large categories, with its algorithm adjusting and learning an individual’s insulin needs over time.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Countries Are Leading the Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

This Report Delivers Insight On:

1. How big is the insulin delivery devices market, and how is it changing globally?

2. Who are the major companies in the insulin delivery devices market, and how are they performing?

3. What are the key opportunities and risks in the insulin delivery devices market right now?

4. Which products or customer segments are growing the most in the insulin delivery devices market?

5. What factors are helping or slowing down the growth of the insulin delivery devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the insulin delivery devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Insulin Delivery Devices Market, and What Factors Will Drive It?

In recent years, there has been substantial growth in the insulin delivery devices market. It is projected to expand from $17.71 billion in 2024 to $19.22 billion in 2025, witnessing a compound annual growth rate (CAGR) of 8.5%. Factors such as the convenience and simplicity of insulin delivery devices, advantageous reimbursement policies, the increasing occurrence of obesity, the rise in the elderly population, and the growing acceptance of insulin pumps, have all contributed to the growth in the historical period.

The market size for insulin delivery devices is projected to experience robust expansion in the forthcoming years. With a compound annual growth rate (CAGR) of 8.2%, it’s expected to reach $26.3 billion by 2029. This acceleration in the predicted period is linked to the increasing prevalence of diabetes, escalating healthcare expenditure on diabetes management, the advent of continuous glucose monitoring systems, increasing patient awareness about the advantages of automated insulin delivery devices and an enhanced focus on healthcare. Noteworthy developments anticipated within this forecast period encompass advancements in insulin delivery device technology, the incorporation of digital technology with insulin delivery devices, progress in the creation of artificial pancreas systems, advancements in insulin administration techniques, and progress in bionic technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Insulin Delivery Devices Market?

The insulin delivery devices market is predicted to expand due to the increasing incidence of diabetes. Diabetes, a persistent ailment characterized by elevated blood glucose levels, arises from insufficient insulin production in the pancreas or the body’s failure to use insulin effectively. The rise in diabetes rates is mainly attributed to inactive lifestyles, unhealthy eating habits, and escalating obesity rates worldwide. Insulin delivery devices aid in the effective management of blood glucose levels in diabetics by providing a controlled and hassle-free insulin administration. This helps stave off complications and fosters better health. The Centers for Disease Control and Prevention, an American government agency, reported in December 2022 that the count of young people under 20 with type 2 diabetes in the United States could surge nearly 700% by 2060, possibly touching 220,000 individuals. Meanwhile, diagnoses of type 1 diabetes among young people could see a potential increase of up to 65% over the same timeframe. Hence, the increasing occurrence of diabetes is fueling the growth of the insulin delivery devices market.

Which Segments in the Insulin Delivery Devices Offer the Most Growth?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Which Areas Are Leading Regions in the Insulin Delivery Devices Market Expansion Across the Globe?

North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Insulin Delivery Devices Industry?

Key players in the insulin delivery devices market are focusing on the design and production of innovative tools like insulin pumps, aimed at offering continuous or tailor-made insulin delivery. Insulin pumps are medical devices equipped with programming abilities, which dispense insulin either continuously or on-demand through a catheter situated beneath the skin. An example of this was seen in May 2023, when US-based medical tech firm, Beta Bionics, secured approval from the U.S. Food and Drug Administration for the iLet ACE Pump and the iLet Dosing Decision Software. Specifically designed for those six years old or above suffering from type 1 diabetes, the iLet Bionic Pancreas system fuses two gadgets compatible with an FDA-approved integrated continuous glucose monitor (iCGM). The system employs an automated insulin dosing (AID) system, governed by an adaptive closed-loop algorithm. This system uses the user’s body weight as the initial setup input and discards the necessity for extra insulin dosing parameters. Setting it apart from traditional pump therapy, it doesn’t need manual adjustment making it more user-friendly to start and monitor. Additionally, the iLet device introduces a user-friendly feature where meals are categorized as small, medium, or large. This simplifies insulin dosing at meal times and the algorithm is capable of learning and adjusting to individual insulin needs over time.

View the full report here:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

What Are the Key Elements That Define the Insulin Delivery Devices Market?

Insulin delivery devices refer to medical tools designed to administer insulin into the body of a person with diabetes. These devices are crucial for managing blood glucose levels in individuals who cannot produce sufficient insulin naturally. These devices are used to manage blood sugar levels effectively, providing flexibility and convenience in insulin administration.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model